Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response

Abstract

The contribution of the insulin-like growth-factor-I receptor (IGF-IR) to tumour progression is well documented. To identify new mediators of IGF-IR function in cancer, we recently isolated genes differentially expressed in cells overexpressing the IGF-IR. Among these was the serine/threonine kinase PBK/TOPK (PDZ-binding kinase/T-LAK cell-originated protein kinase), previously associated with highly proliferative cells and tissues. Here, we show that PBK is expressed at high levels in tumour cell lines compared with non-transformed cells. IGF-I could induce PBK expression only in transformed cells, whereas epidermal growth factor could induce PBK in non-transformed MCF-10A breast epithelial cells. Suppression of PBK expression using small interfering RNA did not prevent progression through the cell cycle, but caused decreased proliferation over time in culture, and reduced clonogenic growth in soft agarose. PBK knockdown impaired p38 activation after long-term stimulation with different growth factors and reduced DU145 cells motility. Suppressed PBK expression also resulted in an impaired response to DNA damage that was evident by the decreased generation of γ-H2AX, increased DNA damage and decreased cell survival. Taken together, the data indicate that PBK is necessary for appropriate activation and function of the p38 pathway by growth factors. Thus, enhanced expression of PBK may facilitate tumour growth by mediating p38 activation and by helping cells to overcome DNA damage.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Abe Y, Matsumoto S, Kito K, Ueda N . (2000). Cloning and expression of a novel MAPKK-like protein kinase, lymphokine-activated killer T-cell-originated protein kinase, specifically expressed in the testis and activated lymphoid cells. J Biol Chem 275: 21525–21531.

    Article  CAS  Google Scholar 

  • Bartucci M, Morelli C, Mauro L, Ando S, Surmacz E . (2001). Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Cancer Res 61: 6747–6754.

    CAS  PubMed  Google Scholar 

  • Cleaver JE . (2005). Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat Rev Cancer 5: 564–573.

    Article  CAS  Google Scholar 

  • Cote S, Simard C, Lemieux R . (2002). Regulation of growth-related genes by interleukin-6 in murine myeloma cells. Cytokine 20: 113–120.

    Article  CAS  Google Scholar 

  • Dendouga N, Gao H, Moechars D, Janicot M, Vialard J, McGowan CH . (2005). Disruption of murine Mus81 increases genomic instability and DNA damage sensitivity but does not promote tumorigenesis. Mol Cell Biol 25: 7569–7579.

    Article  CAS  Google Scholar 

  • Dougherty JD, Garcia AD, Nakano I, Livingstone M, Norris B, Polakiewicz R et al. (2005). PBK/TOPK, a proliferating neural progenitor-specific mitogen-activated protein kinase kinase. J Neurosci 25: 10773–10785.

    Article  CAS  Google Scholar 

  • Dupont J, Dunn SE, Barrett JC, LeRoith D . (2003). Microarray analysis and identification of novel molecules involved in insulin-like growth factor-1 receptor signaling and gene expression. Recent Prog Horm Res 58: 325–342.

    Article  CAS  Google Scholar 

  • Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A . (2004). H2AX: the histone guardian of the genome. DNA Repair (Amsterdam) 3: 959–967.

    Article  CAS  Google Scholar 

  • Friedmann B, Caplin M, Hartley JA, Hochhauser D . (2004). Modulation of DNA repair in vitro after treatment with chemotherapeutic agents by the epidermal growth factor receptor inhibitor gefitinib (ZD1839). Clin Cancer Res 10: 6476–6486.

    Article  CAS  Google Scholar 

  • Fujibuchi T, Abe Y, Takeuchi T, Ueda N, Shigemoto K, Yamamoto H et al. (2005). Expression and phosphorylation of TOPK during spermatogenesis. Dev Growth Differ 47: 637–644.

    Article  CAS  Google Scholar 

  • Gaudet S, Branton D, Lue RA . (2000). Characterization of PDZ-binding kinase, a mitotic kinase. Proc Natl Acad Sci USA 97: 5167–5172.

    Article  CAS  Google Scholar 

  • Heron-Milhavet L, Karas M, Goldsmith CM, Baum BJ, LeRoith D . (2001). Insulin-like growth factor-I (IGF-I) receptor activation rescues UV-damaged cells through a p38 signaling pathway. Potential role of the IGF-I receptor in DNA repair. J Biol Chem 276: 18185–18192.

    Article  CAS  Google Scholar 

  • Heron-Milhavet L, LeRoith D . (2002). Insulin-like growth factor I induces MDM2-dependent degradation of p53 via the p38 MAPK pathway in response to DNA damage. J Biol Chem 277: 15600–15606.

    Article  CAS  Google Scholar 

  • Hofmann F, Garcia-Echeverria C . (2005). Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer. Drug Discov Today 10: 1041–1047.

    Article  CAS  Google Scholar 

  • Huang C, Jacobson K, Schaller MD . (2004). MAP kinases and cell migration. J Cell Sci 117: 4619–4628.

    Article  CAS  Google Scholar 

  • Kiely PA, Leahy M, O'Gorman D, O'Connor R . (2005). RACK1-mediated integration of adhesion and insulin-like growth factor I (IGF-I) signaling and cell migration are defective in cells expressing an IGF-I receptor mutated at tyrosines 1250 and 1251. J Biol Chem 280: 7624–7633.

    Article  CAS  Google Scholar 

  • Kim MS, Lee EJ, Kim HR, Moon A . (2003). p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res 63: 5454–5461.

    CAS  Google Scholar 

  • Lee-Kwon W, Park D, Bernier M . (1998). Nucleotide excision repair is not required for the antiapoptotic function of insulin-like growth factor 1. Exp Cell Res 241: 458–466.

    Article  CAS  Google Scholar 

  • Lisby M, Rothstein R . (2004). DNA damage checkpoint and repair centers. Curr Opin Cell Biol 16: 328–334.

    Article  CAS  Google Scholar 

  • Loughran G, Healy NC, Kiely PA, Huigsloot M, Kedersha NL, O'Connor R . (2005a). Mystique is a new insulin-like growth factor-I-regulated PDZ-LIM domain protein that promotes cell attachment and migration and suppresses Anchorage-independent growth. Mol Biol Cell 16: 1811–1822.

    Article  CAS  Google Scholar 

  • Loughran G, Huigsloot M, Kiely PA, Smith LM, Floyd S, Ayllon V et al. (2005b). Gene expression profiles in cells transformed by overexpression of the IGF-I receptor. Oncogene 24: 6185–6193.

    Article  CAS  Google Scholar 

  • Macaulay VM, Salisbury AJ, Bohula EA, Playford MP, Smorodinsky NI, Shiloh Y . (2001). Downregulation of the type 1 insulin-like growth factor receptor in mouse melanoma cells is associated with enhanced radiosensitivity and impaired activation of ATM kinase. Oncogene 20: 4029–4040.

    Article  CAS  Google Scholar 

  • Madhusudan S, Hickson ID . (2005). DNA repair inhibition: a selective tumour targeting strategy. Trends Mol Med 11: 503–511.

    Article  CAS  Google Scholar 

  • Maldonado C, Cea P, Adasme T, Collao A, Diaz-Araya G, Chiong M et al. (2005). IGF-1 protects cardiac myocytes from hyperosmotic stress-induced apoptosis via CREB. Biochem Biophys Res Commun 336: 1112–1118.

    Article  CAS  Google Scholar 

  • Marti TM, Hefner E, Feeney L, Natale V, Cleaver JE . (2006). H2AX phosphorylation within the G1 phase after UV irradiation depends on nucleotide excision repair and not DNA double-strand breaks. Proc Natl Acad Sci USA 103: 9891–9896.

    Article  CAS  Google Scholar 

  • Matsumoto S, Abe Y, Fujibuchi T, Takeuchi T, Kito K, Ueda N et al. (2004). Characterization of a MAPKK-like protein kinase TOPK. Biochem Biophys Res Commun 325: 997–1004.

    Article  CAS  Google Scholar 

  • Mauro L, Surmacz E . (2004). IGF-I receptor, cell–cell adhesion, tumour development and progression. J Mol Histol 35: 247–253.

    Article  CAS  Google Scholar 

  • Mikhailov A, Shinohara M, Rieder CL . (2005). The p38-mediated stress-activated checkpoint. A rapid response system for delaying progression through antephase and entry into mitosis. Cell Cycle 4: 57–62.

    Article  CAS  Google Scholar 

  • Mulligan C, Rochford J, Denyer G, Stephens R, Yeo G, Freeman T et al. (2002). Microarray analysis of insulin and insulin-like growth factor-1 (IGF-1) receptor signaling reveals the selective up-regulation of the mitogen heparin-binding EGF-like growth factor by IGF-1. JBiol Chem 277: 42480–42487.

    Article  CAS  Google Scholar 

  • Nandi A, Tidwell M, Karp J, Rapoport AP . (2004). Protein expression of PDZ-binding kinase is up-regulated in hematologic malignancies and strongly down-regulated during terminal differentiation of HL-60 leukemic cells. Blood Cells Mol Dis 32: 240–245.

    Article  CAS  Google Scholar 

  • Nandi AK, Rapoport AP . (2006). Expression of PDZ-binding kinase (PBK) is regulated by cell cycle-specific transcription factors E2F and CREB/ATF. Leuk Res 30: 437–447.

    Article  CAS  Google Scholar 

  • O'Connor R . (2003). Regulation of IGF-I receptor signaling in tumor cells. Horm Metab Res 35: 771–777.

    Article  CAS  Google Scholar 

  • Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM . (2000). A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 10: 886–895.

    Article  CAS  Google Scholar 

  • Risinger MA, Groden J . (2004). Crosslinks and crosstalk: human cancer syndromes and DNA repair defects. Cancer Cell 6: 539–545.

    CAS  PubMed  Google Scholar 

  • Rochester MA, Riedemann J, Hellawell GO, Brewster SF, Macaulay VM . (2005). Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer. Cancer Gene Ther 12: 90–100.

    Article  CAS  Google Scholar 

  • Sartor CI . (2004). Mechanisms of disease: radiosensitization by epidermal growth factor receptor inhibitors. Nat Clin Pract Oncol 1: 80–87.

    Article  CAS  Google Scholar 

  • Sell C, Rubini M, Rubin R, Liu JP, Efstratiadis A, Baserga R . (1993). Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl Acad Sci USA 90: 11217–11221.

    Article  CAS  Google Scholar 

  • Shen WH, Yin Y, Broussard SR, McCusker RH, Freund GG, Dantzer R et al. (2004). Tumor necrosis factor alpha inhibits cyclin A expression and retinoblastoma hyperphosphorylation triggered by insulin-like growth factor-I induction of new E2F-1 synthesis. J Biol Chem 279: 7438–7446.

    Article  CAS  Google Scholar 

  • Simons-Evelyn M, Bailey-Dell K, Toretsky JA, Ross DD, Fenton R, Kalvakolanu D et al. (2001). PBK/TOPK is a novel mitotic kinase which is upregulated in Burkitt's lymphoma and other highly proliferative malignant cells. Blood Cells Mol Dis 27: 825–829.

    Article  CAS  Google Scholar 

  • Sorensen CS, Hansen LT, Dziegielewski J, Syljuasen RG, Lundin C, Bartek J et al. (2005). The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat Cell Biol 7: 195–201.

    Article  CAS  Google Scholar 

  • Speit G, Hartmann A . (1999). The comet assay (single-cell gel test). A sensitive genotoxicity test for the detection of DNA damage and repair. Methods Mol Biol 113: 203–212.

    CAS  PubMed  Google Scholar 

  • Stiff T, O'Driscoll M, Rief N, Iwabuchi K, Lobrich M, Jeggo PA . (2004). ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res 64: 2390–2396.

    Article  CAS  Google Scholar 

  • Stucki M, Clapperton JA, Mohammad D, Yaffe MB, Smerdon SJ, Jackson SP . (2005). MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks. Cell 123: 1213–1226.

    Article  CAS  Google Scholar 

  • Surmacz E . (2003). Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor. Oncogene 22: 6589–6597.

    Article  CAS  Google Scholar 

  • Trojanek J, Ho T, Del Valle L, Nowicki M, Wang JY, Lassak A et al. (2003). Role of the insulin-like growth factor I/insulin receptor substrate 1 axis in Rad51 trafficking and DNA repair by homologous recombination. Mol Cell Biol 23: 7510–7524.

    Article  CAS  Google Scholar 

  • Vincent AM, Feldman EL . (2002). Control of cell survival by IGF signaling pathways. Growth Horm IGF Res 12: 193–197.

    Article  CAS  Google Scholar 

  • Wang WD, Chen ZT, Li DZ, Cao ZH, Sun SL, Pu P et al. (2005). Correlation between DNA repair capacity in lymphocytes and acute side effects to skin during radiotherapy in nasopharyngeal cancer patients. Clin Cancer Res 11: 5140–5145.

    Article  CAS  Google Scholar 

  • Yacoub A, McKinstry R, Hinman D, Chung T, Dent P, Hagan MP . (2003). Epidermal growth factor and ionizing radiation up-regulate the DNA repair genes XRCC1 and ERCC1 in DU145 and LNCaP prostate carcinoma through MAPK signaling. Radiat Res 159: 439–452.

    Article  CAS  Google Scholar 

  • Yang S, Chintapalli J, Sodagum L, Baskin S, Malhotra A, Reiss K et al. (2005). Activated IGF-1R inhibits hyperglycemia-induced DNA damage and promotes DNA repair by homologous recombination. Am J Physiol Renal Physiol 289: F1144–F1152.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was funded by Science Foundation Ireland and the Health Research Board. We want to thank Dr C Morrison for kindly providing the protocol for γ-H2AX staining and for valuable comments and discussion. We are also grateful to K Tidmore for preparing the illustrations and to our colleagues for helpful discussions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R O'Connor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ayllón, V., O'Connor, R. PBK/TOPK promotes tumour cell proliferation through p38 MAPK activity and regulation of the DNA damage response. Oncogene 26, 3451–3461 (2007). https://doi.org/10.1038/sj.onc.1210142

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1210142

Keywords

This article is cited by

Search

Quick links